Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
- PMID: 10499443
- DOI: 10.1097/00005072-199909000-00011
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
Abstract
Accumulation of paired helical filaments (PHFs) in neurofibrillary tangles, neuropil threads, and dystrophic neurites is one of the major neuropathological hallmarks of Alzheimer disease (AD). The principal protein subunit of PHFs is the abnormally hyperphosphorylated tau. Glycogen synthase kinase 3beta (GSK-3beta) is one of the candidate kinases involved in PHF-tau formation. To play a role in PHF-tau formation, it would be expected that GSK-3beta is active in tangle bearing neurons. In the present study, we investigated the regional and intracellular distributions of active and inactive forms of GSK-3beta in brains staged for neurofibrillary changes. We found that neurons with tangle-like inclusions positive for active, but not inactive, GSK-3beta appear initially in the Pre-alpha layer of the entorhinal cortex and extend to other brain regions, coincident with the sequence of the development of neurofibrillary changes. Active, but not inactive, GSK-3beta was found to initially accumulate in the cytoplasm of pretangle neurons. These data provide direct in situ evidence that is consistent with the involvement of GSK-3beta in PHF-tau formation.
Similar articles
-
The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.Acta Neuropathol. 2002 Feb;103(2):91-9. doi: 10.1007/s004010100435. Epub 2001 Nov 29. Acta Neuropathol. 2002. PMID: 11810173
-
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.Curr Biol. 1994 Dec 1;4(12):1077-86. doi: 10.1016/s0960-9822(00)00246-3. Curr Biol. 1994. PMID: 7704571
-
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13. Acta Neuropathol. 2002. PMID: 12410379
-
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15. J Neural Transm Suppl. 1998. PMID: 9700655 Review.
-
GSK-3 is essential in the pathogenesis of Alzheimer's disease.J Alzheimers Dis. 2006;9(3 Suppl):309-17. doi: 10.3233/jad-2006-9s335. J Alzheimers Dis. 2006. PMID: 16914869 Review.
Cited by
-
Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.Int J Mol Sci. 2024 Sep 23;25(18):10187. doi: 10.3390/ijms251810187. Int J Mol Sci. 2024. PMID: 39337671 Free PMC article. Review.
-
Melatonin: A potential nighttime guardian against Alzheimer's.Mol Psychiatry. 2024 Aug 11. doi: 10.1038/s41380-024-02691-6. Online ahead of print. Mol Psychiatry. 2024. PMID: 39128995 Review.
-
Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.Pharmaceutics. 2024 Jul 19;16(7):955. doi: 10.3390/pharmaceutics16070955. Pharmaceutics. 2024. PMID: 39065652 Free PMC article.
-
Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.Int J Mol Sci. 2023 Jul 10;24(14):11275. doi: 10.3390/ijms241411275. Int J Mol Sci. 2023. PMID: 37511037 Free PMC article. Review.
-
Altered Tau Kinase Activity in rTg4510 Mice after a Single Interfaced CHIMERA Traumatic Brain Injury.Int J Mol Sci. 2023 May 29;24(11):9439. doi: 10.3390/ijms24119439. Int J Mol Sci. 2023. PMID: 37298388 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
